Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

CRSPCRSP
18 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in CRISPR THERAPEUTICS AG

Yes. Charles Schwab Investment Management holds 1,057,837 shares of CRSP (Crispr Therapeutics), worth $57.7M, as of its Q2 2026 13F filing. It increased the position by 18,488 shares (+1.8%) from Q1 2026. Charles Schwab Investment Management has held CRSP since Q1 2022, across 18 quarterly 13F filings.

Current Value

$57.7M

Current Shares

1.1M

Total Value Change

+$35.4M

Total Shares Change

+703,034

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+1.8%
$57.7M0.0%$54.54
30
2026-Q1
Increased
1M
+0.9%
$49.4M0.0%$47.57
29
2025-Q4
Increased
1M
+4.5%
$54M0.0%$52.44
31
2025-Q3
Increased
985,770
+5.6%
$63.9M0.0%$64.81
31
2025-Q2
Increased
933,204
+30.8%
$45.4M0.0%$48.64
37
2025-Q1
Decreased
713,539
-1.3%
$24.3M0.0%$34.03
0
2024-Q4
Decreased
723,032
-0.2%
$28.5M0.0%$39.36
0
2024-Q3
Increased
724,241
+0.9%
$34M0.0%$46.98
29
2024-Q2
Increased
717,606
+7.2%
$38.8M0.0%$54.01
31
2024-Q1
Increased
669,192
+2.5%
$45.6M0.0%$68.16
30
2023-Q4
Increased
653,023
+2.4%
$40.9M0.0%$62.60
30
2023-Q3
Decreased
637,938
-1.4%
$29M0.0%$45.39
0
2023-Q2
Increased
646,711
+0.9%
$36.3M0.0%$56.14
29
2023-Q1
Decreased
640,777
-0.1%
$29M0.0%$45.23
0
2022-Q4
Increased
641,094
+3.0%
$26.1M0.0%$40.65
30
2022-Q3
Increased
622,118
+78.7%
$40.7M0.0%$65.35
44
2022-Q2
Decreased
348,123
-1.9%
$21.2M0.0%$60.77
0
2022-Q1
New
354,803
-
$22.3M0.0%$62.77
39

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used